Quotient Clinical expands into USA through acquisition of SeaView Research
Quotient Clinical announces second US acquisition: QS Pharma
The choice the majority of voters made in the EU
Referendum was not the one that the CCRA had hoped for. It has caused,
and will continue to cause, a great deal of uncertainty in the UK
economy and it is not clear to anyone what the long term consequences
will be to our members or the UK as a whole. Nevertheless the European
Medicines Agency’s Executive Director, Guido Rasi, said that in the
short term “all of the Agency’s operations and procedures will continue
as before” and the fall in the pound against the euro and dollar will
give our members a competitive advantage.
During this time of uncertainty the CCRA will continue to support its
members and to promote the UK as the country with the highest expertise,
best infrastructure and the facilities to support effective drug and
Professor Atholl Johnston
President of CCRA
The Clinical & Contract Research Association (CCRA) is the voice for all organisations
which provide clinical and contract development services for the
pharmaceutical and biotechnology industries.
here to support those people who choose to take part in clinical trials.
CCRA helps ensure that patients and volunteers receive the very best
professional attention and information through every stage of their
participation in trials.
Members of the CCRA enjoy many positive benefits, click
here to find out more
Our members range from large organisations to small companies plus
View member profiles
If you have an interest in joining clinical trials, the relevant pages
on this site will give you plenty of insight into the whole process:
The Clinical & Contract Research Association (CCRA) Launches Affiliate
click here to
read the statement.